• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期激活 Toll 样受体 3 可减轻 APP/PS1 小鼠阿尔茨海默病的病理进展。

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP/PS1 mouse.

机构信息

Institute of Neurological Diseases, Xuzhou Medical University, Xuzhou, China.

Department of Human Anatomy, Kangda College of Nanjing Medical University, Lianyungang, China.

出版信息

Alzheimers Res Ther. 2023 Feb 16;15(1):33. doi: 10.1186/s13195-023-01186-w.

DOI:10.1186/s13195-023-01186-w
PMID:36797783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9933297/
Abstract

BACKGROUND

Toll-like receptor 3 (TLR3) plays an important role in the immune/inflammatory response in the nervous system and is a main pathological feature of Alzheimer's disease (AD). This study investigates the role of early activation of TLR3 in the pathophysiological process of AD.

METHODS

In the experiment, the agonist of TLR3, Poly(I:C), was intraperitoneally injected into the APP/PS1 mouse model of AD and wild-type control mice starting from the age of 4 to 9 months. At the age of 14 months, behavioral tests were conducted. Western blot and immunohistochemistry staining were used to evaluate the level of amyloid β-protein (Aβ), the activation of inflammatory cells, and neuron loss. In addition, the levels of inflammatory cytokines were measured using a quantitative polymerase chain reaction.

RESULTS

The results demonstrated that the early activation of TLR3 attenuated neuronal loss and neurobehavioral dysfunction. Moreover, the early activation of TLR3 reduced Aβ deposition, inhibited the activation of microglia and astrocytes, and decreased the transcription of pro-inflammatory factors in the hippocampus.

CONCLUSIONS

The results indicated that the activation of TLR3 by Poly (I:C) in the early stage of development of AD in a mouse model attenuated neuron loss and improved neurobehavioral functions. The underlying mechanisms could be attributed to its role in Aβ clearance, the inhibition of glial cells, and the regulation of neuroinflammation in the hippocampus.

摘要

背景

Toll 样受体 3(TLR3)在神经系统的免疫/炎症反应中发挥重要作用,是阿尔茨海默病(AD)的主要病理特征。本研究探讨了 TLR3 的早期激活在 AD 病理生理过程中的作用。

方法

在实验中,从 4 月龄到 9 月龄,TLR3 的激动剂 Poly(I:C)通过腹腔注射到 AD 的 APP/PS1 小鼠模型和野生型对照小鼠中。在 14 月龄时,进行行为测试。使用 Western blot 和免疫组织化学染色来评估淀粉样β蛋白(Aβ)、炎症细胞激活和神经元丢失的水平。此外,使用定量聚合酶链反应测量炎症细胞因子的水平。

结果

结果表明,TLR3 的早期激活减轻了神经元丢失和神经行为功能障碍。此外,TLR3 的早期激活减少了 Aβ 沉积,抑制了小胶质细胞和星形胶质细胞的激活,并降低了海马体中促炎因子的转录。

结论

结果表明,在 AD 小鼠模型的早期发育阶段,Poly(I:C)激活 TLR3 减轻了神经元丢失并改善了神经行为功能。其潜在机制可能与其在 Aβ 清除、胶质细胞抑制和海马体神经炎症调节中的作用有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/b847bfcd222f/13195_2023_1186_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/997ac8e9919b/13195_2023_1186_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/5033fdf4ff2d/13195_2023_1186_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/5451df67470b/13195_2023_1186_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/7551c68da9c6/13195_2023_1186_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/b847bfcd222f/13195_2023_1186_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/997ac8e9919b/13195_2023_1186_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/5033fdf4ff2d/13195_2023_1186_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/5451df67470b/13195_2023_1186_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/7551c68da9c6/13195_2023_1186_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/9933297/b847bfcd222f/13195_2023_1186_Fig8_HTML.jpg

相似文献

1
Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP/PS1 mouse.早期激活 Toll 样受体 3 可减轻 APP/PS1 小鼠阿尔茨海默病的病理进展。
Alzheimers Res Ther. 2023 Feb 16;15(1):33. doi: 10.1186/s13195-023-01186-w.
2
Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.小胶质细胞通过抑制神经胶质淋巴清除来防止阿尔茨海默病小鼠模型早期β-淀粉样斑块的形成。
Alzheimers Res Ther. 2020 Oct 2;12(1):125. doi: 10.1186/s13195-020-00688-1.
3
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.二氢杨梅素通过抑制 APP/PS1 转基因小鼠中 NLRP3 炎性小体的激活来抑制小胶质细胞的激活和神经炎症。
CNS Neurosci Ther. 2018 Dec;24(12):1207-1218. doi: 10.1111/cns.12983. Epub 2018 Jun 4.
4
Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.腹膜透析可降低人类血液中的淀粉样蛋白-β水平,并减轻 APP/PS1 小鼠模型的阿尔茨海默病相关表型。
Acta Neuropathol. 2017 Aug;134(2):207-220. doi: 10.1007/s00401-017-1721-y. Epub 2017 May 5.
5
Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.苯并(a)芘暴露可导致 APP/PS1 小鼠神经元丢失、斑块沉积和认知功能下降。
J Neuroinflammation. 2020 Aug 31;17(1):258. doi: 10.1186/s12974-020-01925-y.
6
Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.栀子酸通过抑制 HMGB-1 并下调 TLR4/2 信号通路改善 APP/PS1 小鼠的空间学习记忆障碍和神经炎症。
Eur J Pharmacol. 2020 Feb 15;869:172857. doi: 10.1016/j.ejphar.2019.172857. Epub 2019 Dec 12.
7
ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.ABCA7基因缺陷加速β淀粉样蛋白生成及阿尔茨海默病的神经元病变。
J Neurosci. 2016 Mar 30;36(13):3848-59. doi: 10.1523/JNEUROSCI.3757-15.2016.
8
Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.淀粉样β蛋白调节阿尔茨海默病小鼠模型中血管周围神经元载脂蛋白 E 的清除。
J Neural Transm (Vienna). 2011 May;118(5):699-712. doi: 10.1007/s00702-010-0572-7. Epub 2011 Jan 6.
9
Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease.抑制 TLR2 激活可减轻阿尔茨海默病小鼠模型中的淀粉样蛋白积累和神经胶质细胞激活。
Brain Behav Immun. 2016 Nov;58:191-200. doi: 10.1016/j.bbi.2016.07.143. Epub 2016 Jul 12.
10
Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.长期跑步机运动可抑制APP/PS1转基因小鼠海马中阿尔茨海默病样神经病理学的进展。
Behav Brain Res. 2013 Nov 1;256:261-72. doi: 10.1016/j.bbr.2013.08.008. Epub 2013 Aug 19.

引用本文的文献

1
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.调节神经炎症作为阿尔茨海默病的一种潜在治疗靶点
Cells. 2025 Jan 22;14(3):168. doi: 10.3390/cells14030168.
2
Xixin Decoction's novel mechanism for alleviating Alzheimer's disease cognitive dysfunction by modulating amyloid-β transport across the blood-brain barrier to reduce neuroinflammation.喜欣汤通过调节淀粉样蛋白β跨血脑屏障的转运以减轻神经炎症来缓解阿尔茨海默病认知功能障碍的新机制。
Front Pharmacol. 2025 Jan 6;15:1508726. doi: 10.3389/fphar.2024.1508726. eCollection 2024.
3
Neurodegenerative diseases reflect the reciprocal roles played by retroelements in regulating memory and immunity.

本文引用的文献

1
Cellular Reprogramming and Its Potential Application in Alzheimer's Disease.细胞重编程及其在阿尔茨海默病中的潜在应用。
Front Neurosci. 2022 Apr 7;16:884667. doi: 10.3389/fnins.2022.884667. eCollection 2022.
2
Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.通过 CpG 寡脱氧核苷酸刺激先天免疫可改善老年松鼠猴的阿尔茨海默病病理。
Brain. 2021 Aug 17;144(7):2146-2165. doi: 10.1093/brain/awab129.
3
Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.
神经退行性疾病反映了逆转录元件在调节记忆和免疫方面所起的相互作用。
Front Neurosci. 2024 Sep 20;18:1445540. doi: 10.3389/fnins.2024.1445540. eCollection 2024.
4
Nucleic Acids-Based Biomarkers for Alzheimer's Disease Diagnosis and Novel Molecules to Treat the Disease.基于核酸的阿尔茨海默病诊断生物标志物和治疗该疾病的新型分子。
Int J Mol Sci. 2024 Jul 19;25(14):7893. doi: 10.3390/ijms25147893.
5
From Immunity to Neurogenesis: Toll-like Receptors as Versatile Regulators in the Nervous System.从免疫到神经发生: Toll 样受体作为神经系统中的多功能调节剂。
Int J Mol Sci. 2024 May 24;25(11):5711. doi: 10.3390/ijms25115711.
6
Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.微生物组-大脑通讯对神经炎症和神经退行性变的影响。
Int J Mol Sci. 2023 Oct 5;24(19):14925. doi: 10.3390/ijms241914925.
7
extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia.提取物增强双链RNA激活的人小胶质细胞促炎细胞因子的产生。
Front Pharmacol. 2023 Apr 12;14:1102465. doi: 10.3389/fphar.2023.1102465. eCollection 2023.
小胶质细胞腺苷受体:从预处理到调节激活细胞中的 M1/M2 平衡。
Cells. 2021 May 7;10(5):1124. doi: 10.3390/cells10051124.
4
The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases.槲皮素通过 miRNA 介导的自由态和包封态发挥神经保护作用对抗神经疾病。
Nutrients. 2021 Apr 16;13(4):1318. doi: 10.3390/nu13041318.
5
Alzheimer's disease: a tale of two diseases?阿尔茨海默病:两种疾病的故事?
Neural Regen Res. 2021 Oct;16(10):1958-1964. doi: 10.4103/1673-5374.308070.
6
Structural and functional understanding of the toll-like receptors. toll 样受体的结构与功能研究
Protein Sci. 2021 Apr;30(4):761-772. doi: 10.1002/pro.4043. Epub 2021 Feb 24.
7
Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression.衰老相关神经变性中的小胶质细胞更替:干预疾病进展的治疗途径。
Cells. 2021 Jan 14;10(1):150. doi: 10.3390/cells10010150.
8
Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis. toll 样受体(TLRs):在癌症发病机制中具有新面貌的免疫受体大家族。
J Cell Mol Med. 2021 Jan;25(2):639-651. doi: 10.1111/jcmm.16214. Epub 2020 Dec 18.
9
Modulation of β-Amyloid Fibril Formation in Alzheimer's Disease by Microglia and Infection.小胶质细胞与感染对阿尔茨海默病中β-淀粉样蛋白纤维形成的调节作用
Front Mol Neurosci. 2020 Nov 26;13:609073. doi: 10.3389/fnmol.2020.609073. eCollection 2020.
10
Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer's Risk Genes Via Suppression of TLR4 Signaling.脂多糖诱导的外泌体 miR-146a 通过抑制 TLR4 信号通路参与阿尔茨海默病风险基因表达的改变。
J Mol Neurosci. 2021 Jun;71(6):1245-1255. doi: 10.1007/s12031-020-01750-1. Epub 2020 Nov 13.